M. A. Ortega

发表

Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors.

L. Meijer, A. Monge, I. Aldana, 2002, Bioorganic & medicinal chemistry.

New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.

A. López de Cerain, A. Monge, M. A. Ortega, 2000, European journal of medicinal chemistry.

Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.

A. López de Cerain, A. Monge, M. A. Ortega, 1998, Farmaco.

Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.

H. Cerecetto, I. Aldana, M. A. Ortega, 2004, Bioorganic & medicinal chemistry letters.

Anti-malarial activity of some 7-chloro-2-quinoxalinecarbonitrile-1,4-di-N-oxide derivatives.

A. Giménez, A. Monge, I. Aldana, 2003, Die Pharmazie.

Anti-Mycobacterium tuberculosis Agents Derived from Quinoxaline-2-carbonitrile and Quinoxaline-2-carbonitrile 1,4-di-N-oxide

A. Monge, I. Aldana, M. A. Ortega, 2002, Arzneimittelforschung.

Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.

I. Tirapu, A. Monge, I. Aldana, 2001, Die Pharmazie.

Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.

A. López de Cerain, A. Monge, M. A. Ortega, 1999, Die Pharmazie.

New Quinoxaline 1,4-Di-N-oxides for Treatment of Tuberculosis

A. López de Cerain, A. Monge, M. A. Ortega, 1999, Arzneimittelforschung.